The Effect of a Brief Psychological Intervention on Reducing Self-harm Repetition: Feasibility Study

December 15, 2017 updated by: National Taiwan University Hospital
Recent research has focused on examining brief interventions for reducing self-harm, such as the volitional help sheet (VHS). The VHS is a theory-based psychological intervention. Two previous studies applying this tool for reducing self-harm repetition showed inconsistent results; one showed reduced subsequent self-reported suicidal ideation and behavior in patients presenting to hospital for self-harm, whilst the other showed no effect on the number of patients who re-presented to hospital with self-harm. The aim of this study is to investigate the feasibility of the VHS intervention amongst self-harm patients in Taiwan and explore its effect on self-harm repetition based on self-reported self-harm, hospital re-presentations with self-harm, and self-harm episodes from a nationwide self-harm registry. It is a two-phase study: first a qualitative study and second an exploratory randomized control trial. The first study is to interview people who self-harm about their perceptions about the VHS on the online platform, to inform the modification of VHS and the best way to intervene. The second is to examine the feasibility and effect of this intervention at the emergency department setting.

Study Overview

Status

Unknown

Detailed Description

Suicide is an important public health issue and leads to substantial social and economic burden. Self-harm is a significant risk factor of subsequent suicide attempt and suicide. However, previously studied interventions for reducing self-harm repetition such as long-term psychological therapies would not be feasible at acute settings such as emergency departments. It is also challenging to maintain patients who self-harm in long-term treatments. The volitional help sheet (VHS) is a brief, theory-based psychological intervention. Two recent studies applying this tool for reducing self-harm repetition showed inconsistent results; one showed reduced subsequent self-reported suicidal ideation and behavior in patients presenting to hospital for self-harm, whilst the other showed no effect on the number of patients who re-presented to hospital with self-harm. To investigate the feasibility of the VHS intervention for self-harm patients and explore its effect on self-harm repetition in Taiwan, the investigators will conduct a two-phase study: first a qualitative study and second an exploratory randomized control trial.

In phase I, the qualitative study, eight patients with recent self-harm will be recruited from the psychiatric ward and interviewed about their perceptions about the VHS and views about the best way to intervene.

In phase II, the exploratory randomized control trial, the investigators will recruit 60 patients presenting to the emergency department following an episode of self-harm. Patients will be randomly assigned (1:1) to the intervention group, which will be given the VHS intervention on an online platform, or the control group to examine the feasibility and effect of this intervention. The primary outcomes will be self-harm repetition based on: i) self-reported self-harm in a telephone based follow-up survey, ii) hospital re-presentations with self-harm based on hospital records, and iii) self-harm episodes from a nationwide self-harm registry, the National Suicide Surveillance System (NSSS). The NSSS includes a web-based reporting system and all emergency departments across the country are asked to report information about all people present to hospitals following an episode of self-harm. In addition, we will report the sub-group analyses for past self-harm hospitalisation according to the suggestion from the study testing VHS on reducing self-harm in United Kingdom.

Study Type

Interventional

Enrollment (Anticipated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 100
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

In phase I

Inclusion Criteria:

  1. With self-harm experience in the past month
  2. Aged 20 years or over

Exclusion Criteria:

  1. With severe hallucinations or delusions or medically unfit for interview
  2. Limited hands movement (e.g. seriously wounded wrists)

In phase II

Inclusion Criteria:

  1. Admitted to the ER following an episode of self-harm
  2. Aged 20 years or over

Exclusion Criteria:

  1. With severe hallucinations or delusions or medically unfit for interview
  2. Limited hands movement (e.g. seriously wounded wrists)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VHS group
Patients will be asked to make links between critical situations and appropriate solutions in the volitional help sheet (VHS).
A sheet includes two columns: one shows critical situations that easily trigger self-harm; other one shows appropriate solutions for patients to prevent self-harm.
No Intervention: Control group
Patients will be asked to read the VHS. This is an active control group. That means all patients in this study will be exposed to situations and solutions in the VHS.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The acceptability of the intervention to patients
Time Frame: within 6 months of study completion
The investigators will conduct face-to-face qualitative interviews to understand the acceptability of the intervention amongst patients.
within 6 months of study completion
The feasibility of intervention delivery at the ER setting
Time Frame: within 6 months of study completion
The investigators will conduct face-to-face qualitative interviews to understand the feasibility of intervention delivery at the ER setting.
within 6 months of study completion
Patient recruitment
Time Frame: Baseline
Recruitment: the proportion of patients who are eligible and invited actually consent to participate.
Baseline
The proportion of participating patients who can be reached by telephone contact at the 3-month follow-up.
Time Frame: 3 months
The proportion of participating patients who can be reached by telephone contact at the 3-month follow-up.
3 months
The proportion of participating patients who can be reached by telephone contact at the 6-month follow-up.
Time Frame: 6 months
The proportion of participating patients who can be reached by telephone contact at the 6-month follow-up.
6 months
The proportion of participating patients who can be traced from the hospital record at the 3-month.
Time Frame: 3 months
The proportion of participating patients who can be traced from the hospital record at the 3-month.
3 months
The proportion of participating patients who can be traced from the hospital record at the 6-month.
Time Frame: 6 months
The proportion of participating patients who can be traced from the hospital record at the 6-month.
6 months
The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 6-month.
Time Frame: 6 months
The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 6-month.
6 months
The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 3-month.
Time Frame: 3 months
The proportion of participating patients whose identity card number can be linked to the nationwide self-harm registry at the 3-month.
3 months
Change in scores on a self-report suicidal behaviors assessment from baseline to 3 months
Time Frame: Baseline, 3 months
As measured by the total score of the Suicidal Behaviors Questionnaire-Revised (SBQ-R), a 4-item scale for assessing suicidal behavior and ideation. The total score ranges from 3 to 18.
Baseline, 3 months
Change in scores on a self-report suicidal behaviors assessment from baseline to 6 months
Time Frame: Baseline, 6 months
As measured by the total score of the Suicidal Behaviors Questionnaire-Revised (SBQ-R), a 4-item scale for assessing suicidal behavior and ideation. The total score ranges from 3 to 18.
Baseline, 6 months
Number of repeat self-harm episodes per person in 3 months after intervention based on hospital records
Time Frame: 3 months
Number of repeat self-harm episodes per person in 3 months after intervention based on hospital records
3 months
Number of repeat self-harm episodes per person in 3 months after intervention recorded in the nationwide self-harm registry
Time Frame: 3 months
Number of repeat self-harm episodes per person in 3 months after intervention recorded in the nationwide self-harm registry
3 months
Number of repeat self-harm episodes per person in 6 months after intervention based on hospital records
Time Frame: 6 months
Number of repeat self-harm episodes per person in 6 months after intervention based on hospital records
6 months
Number of repeat self-harm episodes per person in 6 months after intervention recorded in the nationwide self-harm registry
Time Frame: 6 months
Number of repeat self-harm episodes per person in 6 months after intervention recorded in the nationwide self-harm registry
6 months
Time to next self-harm repetition (in days) following randomization
Time Frame: 6 months
Time to next self-harm repetition (in days) following randomization according to hospital records and a nationwide self-harm registry.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Times of use of the volitional help sheet
Time Frame: 6 months
Times of use of the volitional help sheet based on the number of visits to the individualized website of the volitional help sheet.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shu-Sen Chang, MD, MSc, PhD, National Taiwan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2017

Primary Completion (Anticipated)

October 1, 2019

Study Completion (Anticipated)

October 1, 2019

Study Registration Dates

First Submitted

November 2, 2017

First Submitted That Met QC Criteria

December 15, 2017

First Posted (Actual)

December 18, 2017

Study Record Updates

Last Update Posted (Actual)

December 18, 2017

Last Update Submitted That Met QC Criteria

December 15, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201708008RINB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide and Self-harm

Clinical Trials on the volitional help sheet

3
Subscribe